Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

Richard P. Chalwin; Ravindranath Tiruvoipati; Giles J. Peek

doi:10.1016/j.ejcts.2008.05.022

Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

Richard P. Chalwin, Ravindranath Tiruvoipati, Giles J. Peek

Research output: Contribution to journal › Article › Other › peer-review

32 Citations (Scopus)

Abstract

Bleeding remains a potential complication for patients requiring extracorporeal life support systems. Recombinant activated factor VII (rFVIIa) is one of the drugs used in controlling bleeding. Its use is generally found to be safe. We report a paediatric patient who developed fatal thrombosis with the use of rFVIIa whilst on extracorporeal membrane oxygenation and discuss the possible factors that lead to fatal thrombosis. Crown

Original language	English
Pages (from-to)	685-686
Number of pages	2
Journal	European Journal of Cardio-Thoracic Surgery
Volume	34
Issue number	3
DOIs	https://doi.org/10.1016/j.ejcts.2008.05.022
Publication status	Published - Sept 2008
Externally published	Yes

Keywords

Bleeding
Extracorporeal membrane oxygenation
Thrombosis

Access to Document

10.1016/j.ejcts.2008.05.022

Cite this

@article{b212047d467442edb9d3a951d0a9053f,

title = "Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation",

abstract = "Bleeding remains a potential complication for patients requiring extracorporeal life support systems. Recombinant activated factor VII (rFVIIa) is one of the drugs used in controlling bleeding. Its use is generally found to be safe. We report a paediatric patient who developed fatal thrombosis with the use of rFVIIa whilst on extracorporeal membrane oxygenation and discuss the possible factors that lead to fatal thrombosis. Crown",

keywords = "Bleeding, Extracorporeal membrane oxygenation, Thrombosis",

author = "Chalwin, {Richard P.} and Ravindranath Tiruvoipati and Peek, {Giles J.}",

year = "2008",

month = sep,

doi = "10.1016/j.ejcts.2008.05.022",

language = "English",

volume = "34",

pages = "685--686",

journal = "European Journal of Cardio-Thoracic Surgery",

issn = "1010-7940",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

AU - Chalwin, Richard P.

AU - Tiruvoipati, Ravindranath

AU - Peek, Giles J.

PY - 2008/9

Y1 - 2008/9

N2 - Bleeding remains a potential complication for patients requiring extracorporeal life support systems. Recombinant activated factor VII (rFVIIa) is one of the drugs used in controlling bleeding. Its use is generally found to be safe. We report a paediatric patient who developed fatal thrombosis with the use of rFVIIa whilst on extracorporeal membrane oxygenation and discuss the possible factors that lead to fatal thrombosis. Crown

AB - Bleeding remains a potential complication for patients requiring extracorporeal life support systems. Recombinant activated factor VII (rFVIIa) is one of the drugs used in controlling bleeding. Its use is generally found to be safe. We report a paediatric patient who developed fatal thrombosis with the use of rFVIIa whilst on extracorporeal membrane oxygenation and discuss the possible factors that lead to fatal thrombosis. Crown

KW - Bleeding

KW - Extracorporeal membrane oxygenation

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=49149132047&partnerID=8YFLogxK

U2 - 10.1016/j.ejcts.2008.05.022

DO - 10.1016/j.ejcts.2008.05.022

M3 - Article

C2 - 18579402

AN - SCOPUS:49149132047

SN - 1010-7940

VL - 34

SP - 685

EP - 686

JO - European Journal of Cardio-Thoracic Surgery

JF - European Journal of Cardio-Thoracic Surgery

IS - 3

ER -

Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

Abstract

Keywords

Access to Document

Other files and links

Cite this